Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6231685

CCc1ccn(CC)n1.Cl

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNH2 known ✓ Q12809 2/20 0.38
GAA known ✓ P10253 1/20 0.31
CSF1R known ✓ P07333 1/20 0.30
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
RAB9A P51151 7/20 0.35
NPC1 O15118 6/20 0.35
SMN1; SMN2 Q16637 4/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
JMJD6 Q6NYC1 1/20 0.33
MAPT P10636 1/20 0.33
EPHX2 P34913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3575823 0.83
Hydrochloric Acid SCHEMBL2052546 0.83 CYP1A2 (0.37) ALDH1A1KCNH2CYP1A2CYP2C9CYP2D6
SCHEMBL859959 0.82
SCHEMBL859677 0.80
SCHEMBL20755604 0.80
SCHEMBL4324417 0.80
SCHEMBL13066711 0.80
SCHEMBL21945129 0.80 KCNH2 (0.37) ALDH1A1KCNH2CYP1A2CYP2C9CYP2D6
SCHEMBL10155081 0.80 RAF1 (0.33) ALDH1A1KMT2APOLB
SCHEMBL24618609 0.77 KCNH2 (0.38) ALDH1A1KCNH2CYP1A2CYP2C9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6911410-B2 Catalyst composition containing an aluminoxane for dimerizing, co-dimerizing and oligomerizing olefins INSTITUT FRANCAIS DU PETROLE (FR) 2005-06-28 US claimed
EP-1136123-B1 Catalytic composition and catalytic process of dimerisation, codimerisation and oligomerisation of olefins INST FRANCAIS DU PETROLE (FR) 2005-05-25 EP claimed
EP-1138388-B1 Catalytic composition for dimerisation, codimerisation and oligomerisation of olefins INST FRANCAIS DU PETROLE (FR) 2005-04-06 EP claimed
US-6706657-B2 USING COORDINATION CATALYST INSTITUT FRANCAIS DU PETROLE (FR) 2004-03-16 US claimed
US-20030181775-A1 Catalyst composition containing an aluminoxane for dimerizing, co-dimerizing and oligomerizing olefins INSTITUT FRANCAIS DU PETROLE (FR) 2003-09-25 US claimed
EP-1122230-B1 Process for the selective dimerisation of propylene principally to ramified dimers INST FRANCAIS DU PETROLE (FR) 2003-06-25 EP claimed
US-20030109766-A1 Catalytic composition for dimerizing, co-dimerizing and oligomerizing olefins INSTITUT FRANCAIS DU PETROLE (FR) 2003-06-12 US claimed
US-6501001-B2 USING NICKEL COMPOUND OR COMPLEX INSTITUT FRANCAIS DU PETROLE (FR) 2002-12-31 US claimed
US-20010049398-A1 Catalytic composition and process for the catalysis of dimerization codimerization and oligomerization of olefins INSTITUT FRANCAIS DU PETROLE (FR) 2001-12-06 US claimed
US-20010018546-A1 Process for selective dimerization of propylene principally into branched dimers INSTITUT FRANCAIS DU PETROLE (FR) 2001-08-30 US claimed
EP-0646412-B1 Catalyst composition and process for the dimerisation of olefins INST FRANCAIS DU PETROLE (FR) 1999-05-19 EP claimed
EP-0709356-B1 Catalytic composition and aliphatic hydrocarbon alkylation process INST FRANCAIS DU PETROLE (FR) 1999-01-13 EP claimed
US-5852130-A Catalytic composition based on transition metal complexes, and a process for the hydrogenation of unsaturated compounds INSTITUT FRANCAIS DU PETROLE (FR) 1998-12-22 US claimed
US-5780702-A Process for displacing the double bond in olefins using a catalytic composition based on transition metal complexes INSTITUT FRANCAIS DU PETROLE (FR) 1998-07-14 US claimed
US-5750455-A Catalytic composition and process for the alkylation of aliphatic hydrocarbons INSTITUT FRANCAIS DU PETROLE (FR) 1998-05-12 US claimed
US-5693585-A CATALYST CONSISTING OF POROUS SUPPORT IMPREGNATED WITH ALUMINUM HALIDE, QUATERNARY AMMONIUM HALIDE AND/OR AMINE HYDROHALIDE, CUPROUS COMPOUND INSTITUT FRANCAIS DU PETROLE (FR) 1997-12-02 US claimed
US-5675051-A Catalytic composition and olefin disproportion process INSTITUT FRANCAIS DU PETROLE (FR) 1997-10-07 US claimed
US-5550306-A Catalytic process for the dimerization of olefins INSTITUT FRANCAIS DU PETROLE (FR) 1996-08-27 US claimed
US-5536689-A Catalytic composition and a process for the dimerization of olefins INSTITUT FRANCAIS DU PETROLE (FR) 1996-07-16 US claimed
US-5525567-A Catalytic composition and olefin disproportion process INSTITUT FRANCAIS DU PETROLE (FR) 1996-06-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049398-A1 Catalytic composition and process for the catalysis of dimerization codimerization and oligomerization of olefins NOTUM, HDHD5, COG7 KCNH2 3827/4885GAA 1405/4885CSF1R 4508/4885
US-20030181775-A1 Catalyst composition containing an aluminoxane for dimerizing, co-dimerizing and oligomerizing olefins AP1M1, AP2M1, COG7 KCNH2 3970/4885GAA 4287/4885CSF1R 3126/4885
US-20010018546-A1 Process for selective dimerization of propylene principally into branched dimers AP1M1, PHPT1, TAF1 KCNH2 2750/4885GAA 2293/4885CSF1R 3962/4885
US-20030109766-A1 Catalytic composition for dimerizing, co-dimerizing and oligomerizing olefins NOTUM, PHOSPHO1, ADH5 KCNH2 3670/4885GAA 3283/4885CSF1R 4315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.